glp 1 who should not take The Science Behind GLP-1 Medications: Facts vs Hype GLP-1 Drugs and Eating Disorders:

Developed in the 1980s by Professor Vladimir Khavinson, epithalon induces telomere elongation, thereby delaying aging of the reproductive and immune systems and increasing the lifespan of organisms

This means that oral GLP-1s require much higher doses just to achieve similar effects, and even then, absorption can vary based on factors like water intake, stomach pH, and timing of meals

Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's disease

In addition, covering the area with clothing can help prevent transferring to other people